drugset / Trial / NCT02186119
A Study of Abicipar Pegol in Patients With Diabetic Macular Edema
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a safety and efficacy study of abicipar pegol in patients with diabetic macular edema.
Timeline
- Start
- 2014-07
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abicipar pegol | Protein / enzyme biologic | 1 mg | Intravitreal |
| Subject | Abicipar pegol | Protein / enzyme biologic | 2 mg | Intravitreal |
| Comparator | Ranibizumab | Monoclonal antibody | — | Intravitreal |